磷能解錠400公絲

Riik: Taiwan

keel: hiina

Allikas: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Laadi alla Infovoldik (PIL)
03-06-2021
Laadi alla Avaliku hindamisaruande (PAR)
11-06-2020

Toimeaine:

SEVELAMER HYDROCHLORIDE

Saadav alates:

台灣中外製藥股份有限公司 台北市松山區敦化北路260號3樓 (23060795)

ATC kood:

V03AE02

Ravimvorm:

膜衣錠

Koostis:

SEVELAMER HYDROCHLORIDE (9200050610) MG

Ühikuid pakis:

瓶裝

Klass:

製 劑

Retsepti tüüp:

須由醫師處方使用

Valmistatud:

GENZYME CORPORATION 500 KENDALL STREET, CAMBRIDGE, MA 02142, U.S.A. US

Terapeutiline ala:

sevelamer

Näidustused:

適用於控制接受透析治療的成年慢性腎病患者的高磷血症。

Toote kokkuvõte:

註銷日期: 2019/03/05; 註銷理由: 自請註銷; 有效日期: 2018/07/31; 英文品名: RENAGEL TABLETS 400MG

Volitamisolek:

已註銷

Loa andmise kuupäev:

2003-07-31

Infovoldik

                                磷能解錠
®
400
公絲
磷能解錠
®
800
公絲
RENAGEL
®
Tablets 400mg
RENAGEL
®
Tablets 800mg
®
(Renagel
®
Tablets)
400
800
023786
023787
2515~30
SEVELAMER HYDROCHLORIDE
製劑
WF400V05
TEL:(02)2658-8800
Genzyme Corporation U.S.A.
【說明】
Renagelsevelamer
hydrochloride
sevelamer hydrochloride
poly(allylamine hydrochloride)
epichlorohydrin
40%poly(allylamine-co-
N,N'-diallyl-1,3-diamino- 2-hydroxypropane) hydrochloride
Sevelamer hydrochloride
NH
2
•
nHCI
a
b
c
m
OH
NH
•
nHCI
NH
2
•
nHCI
NH
•
nHCI
a,b= a+b=9
c=
c=1
n=
n=0.4
m=
poly(allylamine hydrochloride)
poly(allylamine
hydrochloride)
2epichlorohydrin
Renagel Tablets 400mg
Renagel Tablets 800mg
Sevelamer Hydrochloride 400mg
Sevelamer Hydrochloride 800mg
TABLET CONTAINS
: Silicon dioxide
colloidal, Stearic acid
FILM-COATING:
HPMC low molecular weight,
HPMC high molecular weight,
Diacetylated monoglycerides
PRINTING INK:
Iron oxide black (E172), HPMC,
Propylene glycol
TABLET CONTAINS
: Silica, colloidal
anhydrous, Stearic acid
FILM-COATING:
HPMC low molecular weight,
HPMC high molecular weight,
Diacetylated monoglycerides
PRINTING INK:
Iron oxide black (E172), HPMC,
Propylene glycol
【適應症】
Renagel
Renagel
【用法˙用量】
()
Renagel800
1,600mg
Renagel 800mg
12Renagel 400mg
24
Renagel
Renagel 800mg
Renagel 400mg
>5.5<7.5mg/dL
3
3
≧7.5及9.0
mg/dL
3
3
≧9.0
mg/dL
3
3
自使用醋酸鈣轉換來的患者:
84(mg
mg)
Renagel
Renagel
Renagel
667mg
()
Renagel 800mg
()
Renagel 400mg
()
所有患者使用
Renagel
之劑量調整:
5.5mg/dL
5.0mg/dL
Renagel 800mg
Renagel 13
Renagel
>5.5mg/dL
3.5~5.5mg/dL
<3.5mg/dL
【臨床藥理學】
作用機轉
Renagel
sevelamer hydrochloride
sevelamer HCI
藥效動力學
sevelamer hydrochloride
sevelamer HCI
sevelamer
HCILDL-15~31%
HDL-
(CKD)
[Ca X P]55mg
2
/dL
2
(PTH)
PTH
(osteitis fibrosa)()
PTH
Renagel
Renagel
Renagel
(LDL)
藥物動力學
16
14
C-sevelamer
hydrochloridesevelamer
hydrochloride
臨床試驗
Renagel
(Renagel
N=24)(Renagel
N=220)
8
52
(Renagel N=256)
Renagel
calcium acetate
                                
                                Lugege kogu dokumenti